首页> 外文期刊>Journal of cellular and molecular medicine. >Construction of co‐expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma
【24h】

Construction of co‐expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma

机译:WGCNA与生存相关的共表达模块的构建,并鉴定胶质母细胞瘤中的潜在预后生物标志物

获取原文
           

摘要

Glioblastoma (GBM) is a malignant brain tumour with poor prognosis. The potential pathogenesis and therapeutic target are still need to be explored. Herein, TCGA expression profile data and clinical information were downloaded, and the WGCNA was conducted. Hub genes which closely related to poor prognosis of GBM were obtained. Further, the relationship between the genes of interest and prognosis of GBM, and immune microenvironment were analysed. Patients from TCGA were divided into high- and low-risk group. WGCNA was applied to the high- and low-risk group and the black module with the lowest preservation was identified which could distinguish the prognosis level of these two groups. The top 10 hub genes which were closely related to poor prognosis of patients were obtained. GO analysis showed the biological process of these genes mainly enriched in: Cell cycle, Progesterone-mediated oocyte maturation and Oocyte meiosis. CDCA5 and CDCA8 were screened out as the genes of interest. We found that their expression levels were closely related to overall survival. The difference analysis resulted from the TCGA database proved both CDCA5 and CDCA8 were highly expressed in GBM. After transfection of U87-MG cells with small interfering RNA, it revealed that knockdown of the CDCA5 and CDCA8 could influence the biological behaviours of proliferation, clonogenicity and apoptosis of GBM cells. Then, single-gene analysis was performed. CDCA5 and CDCA8 both had good correlations with genes that regulate cell cycle in the p53 signalling pathway. Moreover, it revealed that high amplification of CDCA5 was correlated with CD8 T cells while CDCA8 with CD4 T cells in GBM. These results might provide new molecular targets and intervention strategy for GBM.? 2021 Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
机译:胶质母细胞瘤(GBM)是一种恶性脑肿瘤,预后差。仍然需要探索潜在的发病机制和治疗目标。在此,下载了TCGA表达谱数据和临床信息,并进行了WGCNA。获得与GBM预后密切相关的轮毂基因。此外,分析了GBM的感兴趣基因与免疫微环境之间的关系。从TCGA患者分为低风险组。 WGCNA应用于高风险组,鉴定了具有最低保存的黑色模块,其可以区分这两组的预后水平。获得了与患者预后不良密切相关的前10位轮毂基因。 GO分析显示这些基因的生物过程主要富集:细胞周期,孕酮介导的卵母细胞成熟和卵母细胞减数分裂。作为感兴趣的基因筛选CDCA5和CDCA8。我们发现,它们的表达水平与整体生存率密切相关。由TCGA数据库产生的差异分析证明了CDCA5和CDCA8在GBM中高度表达。用小干扰RNA转染U87-Mg细胞后,揭示了CDCA5和CDCA8的敲低可以影响GBM细胞增殖,克隆性和凋亡的生物学行为。然后,进行单基因分析。 CDCA5和CDCA8均与调节P53信号通路中调节细胞周期的基因具有良好的相关性。此外,揭示了CDCA5的高扩增与CD8 T细胞相关,同时CDCA8与GBM中的CD4 T细胞。这些结果可能为GBM提供新的分子目标和干预策略。 2021人作者。细胞和分子医学基础和约翰瓦里和儿子有限公司出版的细胞和分子医学杂志

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号